56
Views
0
CrossRef citations to date
0
Altmetric
Review

Diagnostic usefulness of myocardial perfusion imaging in patients reluctant to undergo angiography

, &
Pages 35-46 | Published online: 18 Apr 2016

References

  • Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012;366:54–63.
  • Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–e322.
  • Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham study. Ann Intern Med. 1978;89:157–161.
  • Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–390.
  • Fihn SD, Gardin JM, Abrams J, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44–e164.
  • Halpern EJ, Fischman D, Savage MP, Koka AR, DeCaro M, Levin DC. Decision analytic model for evaluation of suspected coronary disease with stress testing and coronary CT angiography. Acad Radiol. 2010; 17:577–586.
  • Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362:886–895.
  • Ammann P, Brunner-La Rocca HP, Angehrn W, Roelli H, Sagmeister M, Rickli H. Procedural complications following diagnostic coronary angiography are related to the operator’s experience and the catheter size. Catheter Cardiovasc Interv. 2003;59:13–18.
  • Schönenberger E, Schnapauff D, Teige F, Laule M, Hamm B, Dewey M. Patient acceptance of noninvasive and invasive coronary angiography. PLoS One. 2007;2:e246.
  • Task Force Members, Montalescot G, Sechtem U, et al; ESC Committee for Practice Guidelines; Document Reviewers. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949–3003.
  • Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991;84:1984–1992.
  • Duncker DJ, Koller A, Merkus D, Canty JM. Regulation of coronary blood flow in health and ischemic heart disease. Prog Cardiovasc Dis. 2015;57:409–422.
  • Ladapo JA, Blecker S, Douglas PS. Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data. Ann Intern Med. 2014;161:482–490.
  • Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–2907.
  • Nudi F, Neri G, Schillaci O, et al. Time to and risk of cardiac events after myocardial perfusion scintigraphy. J Cardiol. 2015;66:125–129.
  • New York University School of Medicine. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) (ISCHEMIA). Available from: https://clinicaltrials.gov/ct2/show/NCT01471522. NLM identifier: NCT01471522. Accessed April 11, 2016.
  • Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516.
  • Windecker S, Stortecky S, Stefanini GG, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. 2014;348:g3859.
  • Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172:312–319.
  • Bangalore S, Pursnani S, Kumar S, Bagos PG. Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease. Circulation. 2013;127:769–781.
  • De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided pci versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001.
  • Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging. 2009;2:412–424.
  • Fazel R, Shaw LJ. Radiation exposure from radionuclide myocardial perfusion imaging: concerns and solutions. J Nucl Cardiol. 2011;18:562–565.
  • Einstein AJ, Pascual TN, Mercuri M, et al. Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS). Eur Heart J. 2015;36:1689–1696.
  • Palyo R, Sinusas A, Liu YH. High-sensitivity and high-resolution SPECT/CT systems provide substantial dose reduction without compromising quantitative precision for assessment of myocardial perfusion or function. J Nucl Med. Epub 2016 Feb 4.
  • Piccinelli M, Garcia EV. Advances in single-photon emission computed tomography hardware and software. Cardiol Clin. 2016;34:1–11.
  • Underwood SR, Anagnostopoulos C, Cerqueira M, et al; British Cardiac Society; British Nuclear Cardiology Society; British Nuclear Medicine Society; Royal College of Physicians of London; Royal College of Radiologists. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004;31:261–291.
  • Takx RA, Blomberg BA, El Aidi H, et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circ Cardiovasc Imaging. 2015;8:e002666.
  • Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379:453–460.
  • Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171–185.
  • Abidov A, Germano G, Berman DS. Transient ischemic dilation ratio: a universal high-risk diagnostic marker in myocardial perfusion imaging. J Nucl Cardiol. 2007;14:497–500.
  • Mannting F, Zabrodina YV, Dass C. Significance of increased right ventricular uptake on 99mtc-sestamibi SPECT in patients with coronary artery disease. J Nucl Med. 1999;40:889–894.
  • Shaw LJ, Weintraub WS, Maron DJ, et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J. 2012;164:243–250.
  • Ghotbi AA, Kjaer A, Hasbak P. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging. Clin Physiol Funct Imaging. 2014;34:163–170.
  • Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007;115:1464–1480.
  • Aggarwal NR, Drozdova A, Wells Askew J, Kemp BJ, Chareonthaitawee P. Feasibility and diagnostic accuracy of exercise treadmill nitrogen-13 ammonia PET myocardial perfusion imaging of obese patients. J Nucl Cardiol. 2015;22(6):1273–1280.
  • Taqueti VR, Di Carli MF. Radionuclide myocardial perfusion imaging for the evaluation of patients with known or suspected coronary artery disease in the era of multimodality cardiovascular imaging. Prog Cardiovasc Dis. 2015;57:644–653.
  • Dorbala S, Di Carli MF. Cardiac PET perfusion: prognosis, risk stratification, and clinical management. Semin Nucl Med. 2014;44:344–357.
  • Waller AH, Blankstein R, Kwong RY, Di Carli MF. Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography. Curr Cardiol Rep. 2014;16:483.
  • Schindler TH. Myocardial blood flow: Putting it into clinical perspective. J Nucl Cardiol. Epub 2015 Dec 28.
  • Hagemann CE, Ghotbi AA, Kjær A, Hasbak P. Quantitative myocardial blood flow with rubidium-82 PET: a clinical perspective. Am J Nucl Med Mol Imaging. 2015;5:457–468.
  • Ohira H, Dowsley T, Dwivedi G, et al. Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease. Future Cardiol. 2014;10:611–631.
  • Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–2224.
  • Pathan F, Marwick TH. Myocardial perfusion imaging using contrast echocardiography. Prog Cardiovasc Dis. 2015;57:632–643.
  • Jayaweera AR, Edwards N, Glasheen WP, Villanueva FS, Abbott RD, Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res. 1994;74:1157–1165.
  • Vogel R, Indermühle A, Reinhardt J, et al. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol. 2005;45:754–762.
  • Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation. 2001;103:2560–2565.
  • Senior R, Janardhanan R, Jeetley P, Burden L. Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure. Circulation. 2005;112:1587–1593.
  • Bhatia VK, Senior R. Contrast echocardiography: evidence for clinical use. J Am Soc Echocardiogr. 2008;21:409–416.
  • Dijkmans PA, Senior R, Becher H, et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol. 2006;48:2168–2177.
  • Tsutsui JM, Mukherjee S, Elhendy A, et al. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl. 2006;12:592–599.
  • Wejner-Mik P, Lipiec P, Kasprzak JD. Long-term prognostic value of dipyridamole stress myocardial contrast echocardiography. Eur J Echocardiogr. 2011;12:762–766.
  • Gaibazzi N, Squeri A, Reverberi C, et al. Contrast stress-echocardiography predicts cardiac events in patients with suspected acute coronary syndrome but nondiagnostic electrocardiogram and normal 12-hour troponin. J Am Soc Echocardiogr. 2011;24:1333–1341.
  • Bhave NM, Freed BH, Yodwut C, et al. Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson. J Cardiovasc Magn Reson. 2012;14:89.
  • Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE. Analysis of myocardial perfusion MRI. J Magn Reson Imaging. 2004;19:758–770.
  • Jerosch-Herold M. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:57.
  • Mordini FE, Haddad T, Hsu LY, et al. Diagnostic accuracy of stress perfusion CMR in comparison with quantitative coronary angiography: fully quantitative, semiquantitative, and qualitative assessment. JACC Cardiovasc Imaging. 2014;7:14–22.
  • Patel AR, Antkowiak PF, Nandalur KR, et al. Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol. 2010;56:561–569.
  • Tsaftaris SA, Zhou X, Tang R, Li D, Dharmakumar R. Detecting myocardial ischemia at rest with cardiac phase-resolved blood oxygen level-dependent cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2013;6:311–319.
  • Jahnke C, Gebker R, Manka R, Schnackenburg B, Fleck E, Paetsch I. Navigator-gated 3d blood oxygen level-dependent CMR at 3.0-t for detection of stress-induced myocardial ischemic reactions. JACC Cardiovasc Imaging. 2010;3:375–384.
  • Manka R, Wissmann L, Gebker R, et al. Multicenter evaluation of dynamic three-dimensional magnetic resonance myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve. Circ Cardiovasc Imaging. 2015;8:e003061.
  • Manka R, Paetsch I, Kozerke S, et al. Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location. Eur Heart J. 2012;33:2016–2024.
  • Tarroni G, Corsi C, Antkowiak PF, et al. Myocardial perfusion: near-automated evaluation from contrast-enhanced MR images obtained at rest and during vasodilator stress. Radiology. 2012;265:576–583.
  • Lancellotti P, Nchimi A, Delierneux C, et al. Biological effects of cardiac magnetic resonance on human blood cells. Circ Cardiovasc Imaging. 2015;8:e003697.
  • Kaufmann PA. Cardiac magnetic resonance imaging: the case for nonionizing radiation protection and the precautionary principle. Circ Cardiovasc Imaging. 2015;8:e003885.
  • Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480–489.
  • Schwitter J, Wacker CM, Wilke N, et al; MR-IMPACT Investigators. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013;34:775–781.
  • Freed BH, Narang A, Bhave NM, et al. Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:108.
  • Pontone G, Andreini D, Bertella E, et al. Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study. Eur Radiol. Epub 2015 Oct 29.
  • Patel AR, Bhave NM, Mor-Avi V. Myocardial perfusion imaging with cardiac computed tomography: state of the art. J Cardiovasc Transl Res. 2013;6:695–707.
  • Varga-Szemes A, Meinel FG, De Cecco CN, Fuller SR, Bayer RR, Schoepf UJ. CT myocardial perfusion imaging. AJR Am J Roentgenol. 2015;204:487–497.
  • Ko BS, Cameron JD, Meredith IT, et al. Computed tomography stress myocardial perfusion imaging in patients considered for revascularization: a comparison with fractional flow reserve. Eur Heart J. 2012;33:67–77.
  • Iwasaki K, Matsumoto T. Myocardial perfusion defect in patients with coronary artery disease demonstrated by 64-multidetector computed tomography at rest. Clin Cardiol. 2011;34:454–460.
  • Kachenoura N, Gaspar T, Lodato JA, et al. Combined assessment of coronary anatomy and myocardial perfusion using multidetector computed tomography for the evaluation of coronary artery disease. Am J Cardiol. 2009;103:1487–1494.
  • Gupta M, Kadakia J, Jug B, Mao SS, Budoff MJ. Detection and quantification of myocardial perfusion defects by resting single-phase 64-slice cardiac computed tomography angiography compared with SPECT myocardial perfusion imaging. Coron Artery Dis. 2013;24:290–297.
  • Rochitte CE, George RT, Chen MY, et al. Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the core320 study. Eur Heart J. 2014;35:1120–1130.
  • Mor-Avi V, Lodato JA, Kachenoura N, et al. Quantitative three-dimensional evaluation of myocardial perfusion during regadenoson stress using multidetector computed tomography. J Comput Assist Tomogr. 2012;36:443–449.
  • Bhave NM, Mor-Avi V, Kachenoura N, et al. Analysis of myocardial perfusion from vasodilator stress computed tomography: does improvement in image quality by iterative reconstruction lead to improved diagnostic accuracy? J Cardiovasc Comput Tomogr. 2014;8:238–245.
  • Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation. 2003;108:1263–1277.
  • Winchester DE, Zhang P, Jadhav MP, Beyth RJ. A cohort study of myocardial perfusion imaging in veteran patients without symptoms: contributing factors and results of testing. Medicine (Baltimore). 2015;94:e1154.
  • Zellweger MJ, Fahrni G, Ritter M, et al; BASKET Investigators. Prognostic value of “Routine” Cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational basket (basel stent kosteneffektivitäts trial) late imaging study. JACC Cardiovasc Interv. 2014;7:615–621.
  • Kishi S, Magalhães TA, Cerci RJ, et al. Total coronary atherosclerotic plaque burden assessment by ct angiography for detecting obstructive coronary artery disease associated with myocardial perfusion abnormalities. J Cardiovasc Comput Tomogr. Epub 2016 Jan 14.
  • Otsuka K, Fukuda S, Tanaka A, et al. Prognosis of vulnerable plaque on computed tomographic coronary angiography with normal myocardial perfusion image. Eur Heart J Cardiovasc Imaging. 2014;15:332–340.
  • Alie N, Eldib M, Fayad ZA, Mani V. Inflammation, atherosclerosis, and coronary artery disease: PET/CT for the evaluation of atherosclerosis and inflammation. Clin Med Insights Cardiol. 2014;8:13–21.
  • Sun ZH, Rashmizal H, Xu L. Molecular imaging of plaques in coronary arteries with PET and SPECT. J Geriatr Cardiol. 2014;11:259–273.
  • Wolk MJ, Bailey SR, Doherty JU, et al; American College of Cardiology Foundation Appropriate Use Criteria Task Force. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63:380–406.